SeaStar Medical (NASDAQ:ICU – Get Free Report) and Ethema Health (OTCMKTS:GRST – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, profitability and earnings.
Volatility & Risk
SeaStar Medical has a beta of -1.04, indicating that its stock price is 204% less volatile than the S&P 500. Comparatively, Ethema Health has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500.
Earnings and Valuation
This table compares SeaStar Medical and Ethema Health”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SeaStar Medical | $140,000.00 | 63.62 | -$24.83 million | ($16.50) | -0.14 |
| Ethema Health | $6.02 million | 0.39 | -$2.06 million | N/A | N/A |
Ethema Health has higher revenue and earnings than SeaStar Medical.
Insider & Institutional Ownership
1.7% of SeaStar Medical shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by insiders. Comparatively, 55.8% of Ethema Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Profitability
This table compares SeaStar Medical and Ethema Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SeaStar Medical | -1,551.08% | -414.50% | -151.13% |
| Ethema Health | -9.35% | N/A | -5.77% |
Analyst Recommendations
This is a summary of recent ratings and target prices for SeaStar Medical and Ethema Health, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SeaStar Medical | 1 | 0 | 0 | 0 | 1.00 |
| Ethema Health | 0 | 0 | 0 | 0 | 0.00 |
SeaStar Medical presently has a consensus target price of $6.00, suggesting a potential upside of 155.32%. Given SeaStar Medical’s stronger consensus rating and higher probable upside, equities research analysts clearly believe SeaStar Medical is more favorable than Ethema Health.
Summary
Ethema Health beats SeaStar Medical on 7 of the 11 factors compared between the two stocks.
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
About Ethema Health
Ethema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. Ethema Health Corporation is based in West Palm Beach, Florida.
Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.
